Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes
Hein, D.W.; Doll, M.A.; Ferguson, R.J.
Proceedings of the Western Pharmacology Society 38: 59-62
1995
ISSN/ISBN: 0083-8969 PMID: 7480023 Document Number: 444811
Document emailed within 1 workday
Related Documents
Flammang, T.J.; Yerokun, T.; Bryant, M.S.; Couch, L.H.; Kirlin, W.G.; Lee, K.J.; Ogolla, F.; Ferguson, R.J.; Talaska, G.; Hein, D.W. 1992: Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene Journal of Pharmacology and Experimental Therapeutics 260(2): 865-871Chung, J.G.; Levy, G.N.; Weber, W.W. 1993: Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(6): 1057-1063
Blin, O.; Sangla, I.; Jouglard, J.; Cottin, C.; Pellissier, J.F.; Serratrice, G. 1992: Axonal neuropathy and salazosulfapyridine: slow-acetylator phenotype Revue Neurologique (Paris) 148(2): 154-156
Yerokun, T.; Kirlin, W.G.; Trinidad, A.; Ferguson, R.J.; Ogolla, F.; Andrews, A.F.; Brady, P.K.; Hein, D.W. 1989: Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(3): 231-237
el-Yazigi, A.; Chaleby, K.; Martin, C.R. 1989: A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites Clinical Chemistry 35(5): 848-851
Hein, D.W.; Kirlin, W.G.; Ogolla, F.; Trinidad, A.; Thompson, L.K.; Ferguson, R.J. 1986: The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(5): 566-573
Tatsumi, K.; Kitamura, S.; Amano, H.; Ueda, K. 1989: Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species Cancer Research 49(8): 2059-2064
Li, J.J.; Li, S.A.; Klicka, J.K.; Parsons, J.A.; Lam, L.K. 1983: Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney Cancer Research 43(11): 5200-5204
Raghupati Sarma, G. 1989: Isoniazid acetylator phenotype Indian Pediatrics 26(2): 197-198
Siegmund, W.; Franke, G.; Meng, S.; Gothe, P.; Meng, W. 1988: N-acetylator phenotypes in hyperthyroidism International Journal of Clinical Pharmacology Therapy and Toxicology 26(8): 397-399
Tannen, R.H.; Weber, W.W. 1980: Inheritance of acetylator phenotype in mice Journal of Pharmacology and Experimental Therapeutics 213(3): 480-484
Wiggan, E.B.; Dennis, S.; Reele, S.B.; Luke, D.R. 1991: Reassessment of dapsone as a marker of acetylator phenotypes International Journal of Clinical Pharmacology Therapy and Toxicology 29(7): 262-268
Ladero, J.M.; González, J.F.; Benítez, J.; Vargas, E.; Fernández, M.J.; Baki, W.; Diaz-Rubio, M. 1991: Acetylator polymorphism in human colorectal carcinoma Cancer Research 51(8): 2098-2100
Reidenberg, M.M.; Martin, J.H. 1974: The acetylator phenotype of patients with systemic lupus erythematosus Drug Metabolism and Disposition: the Biological Fate of Chemicals 2(1): 71-73
Kanner, S.B.; Parsons, S.J.; Parsons, J.T.; Gilmer, T.M. 1988: Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells Oncogene 2(4): 327-335
Najim, R.A.; Farid, Y.Y.; Shihab, S.A. 2004: Acetylator phenotype in Iraqi patients with discoid lupus erythematosus Saudi Medical Journal 25(10): 1530-1532
Surana, M.K.; Mathur, A.K.; Banerjee, K.; Agarwal, T.D. 1982: Correlation between acetylator phenotype and neuropathy in diabetes mellitus patients Journal of the Association of Physicians of India 30(7): 437-439
Rohla, M.; Várnai, Z.; Balázsi, I. 1983: Acetylator state in diabetes mellitus and ischemic heart disease Orvosi Hetilap 124(31): 1865-1866
Gachályi, B.; Vas, A.; Csillag, K.; Nagy, B.; Kocsis, F.; Káldor, A. 1986: The acetylator phenotype affects the antipyrine metabolism inhibiting action of cimetidine Orvosi Hetilap 127(25): 1495-1497
Whelpton, R.; Watkins, G.; Curry, S.H. 1981: Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status Clinical Chemistry 27(11): 1911-1914